Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
02/2003
02/13/2003WO2002046378A3 Alternative pol k nucleotide and amino acid sequence and methods for using
02/13/2003WO2002044731A3 Use of intramolecularly, covalently cross-linked proteins as binding partners in immunoassays
02/13/2003WO2002044357A3 Methods of using 18903 to treat pain and pain-related disorders
02/13/2003WO2002040462A3 Cysteine protease inhibitors
02/13/2003WO2002038780A3 Use of a nucleic acid to provide a plant with resistance to attack by a pathogen
02/13/2003WO2002033114A3 Protein-protein interactions in neurodegenerative diseases
02/13/2003WO2002032958A3 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
02/13/2003WO2002030543A9 Continuously operable rotating drum pressure differential filter, method and systems
02/13/2003WO2002020747A3 Regulation of human tyrosine phosphatase-like enzyme
02/13/2003WO2002018565A3 Regulation of human protein phosphatase iic-like enzyme
02/13/2003WO2002004613A3 Isolated polynucleotides encoding human 5'-nucleotide cn-ia and cn-ib, isolated proteins encoded by the same, and methods utilizing the same
02/13/2003WO2002000863A3 32140, a novel human aldehyde dehydrogenase and uses therefor
02/13/2003WO2002000862A8 32447, a novel human acyltransferase and uses thereof
02/13/2003WO2002000702A3 Regulation of human epidermis-specific serine protease
02/13/2003WO2001067855A3 Transgenic mice containing targeted gene disruptions
02/13/2003US20030033634 Nucleotide sequences for use in monitoring sugar depletion in plants
02/13/2003US20030033633 Genes for microsomal delta-12 fatty acid desaturases and related enzymes from plants
02/13/2003US20030033629 RecA proteins
02/13/2003US20030033627 Nucleotide sequences coding polypeptide for use in the generation of disease resistant plants
02/13/2003US20030032789 Nucleotide sequences coding enzymatic polypeptide for use as antiinflammatory agent
02/13/2003US20030032785 Detection of ligand and ligand sequences in sample; obtain nucleotide sequence samples, partitioning sample, incubate with primers, propagate and amplify sequences
02/13/2003US20030032775 Effector proteins of rapamycin
02/13/2003US20030032769 Second mammalian tankyrase
02/13/2003US20030032649 Chimerizing protein kinases for drug discovery
02/13/2003US20030032615 Lipid-mediated polynucleotide administration to deliver a biologically active peptide and to induce a cellular immune response
02/13/2003US20030032596 Administering a compound that modulates the synthesis or expression of a target cellular gene, especially a Src kinase.
02/13/2003US20030032187 Selective antibody targeting of undifferentiated stem cells
02/13/2003US20030032186 Method for stable chromosomal multi-copy integration of genes
02/13/2003US20030032169 Nucleotide sequences coding polypeptide for use in the treatment of cancer, skin and vision defects
02/13/2003US20030032166 Aortic carboxypeptidase-like protein and nucleic acids encoding same
02/13/2003US20030032165 Nucleotide sequences coding enzymatic polypeptide for use in food procssing, generation of protein hydrolysates and wine fermentation
02/13/2003US20030032164 Novel matrix metalloproteinases
02/13/2003US20030032163 Glucoamylase variants
02/13/2003US20030032162 Enzymatic polypeptide for use in detergents and textile processing
02/13/2003US20030032161 Esterase enzymes, DNA encoding esterase enzymes and vectors and host cells incorporating same
02/13/2003US20030032160 Nucleotide sequences coding protein for use in treatment of cancer, inflammation, arthritis and psoriasis
02/13/2003US20030032158 Method of modulating the efficiency of translation termination and degradation of aberrant mRNA involving a surveillance complex comprising human Upf1p,eucaryotic release factor 1 and eucaryotic release factor 3
02/13/2003US20030032156 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders
02/13/2003US20030032155 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/13/2003US20030032153 Novel (R)-2,3-butanediol dehydrogenase, methods for producing same, and methods for producing optically active alcohol using the dehydrogenase
02/13/2003US20030032152 Genetically engineered yeast for use in the generation of lactic acid
02/13/2003US20030032138 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/13/2003US20030032135 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/13/2003US20030032119 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/13/2003US20030032100 Genes encoding desulfurization enzymes
02/13/2003US20030032093 Production of secreted polypeptides
02/13/2003US20030032091 48120, 23479 and 46689, novel human hydrolases and uses thereof
02/13/2003US20030032086 Mixture for use as tool in propagation of nucleotide sequences
02/13/2003US20030032078 Screening therapies for vision defects; obtain sample containing oxidoreductase, incubate with modulator, monitor sample for reduction in enzyme activity
02/13/2003US20030032075 Monoclonal or recombinant antibody for use in the treatment of tumors
02/13/2003US20030032063 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/13/2003US20030032062 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/13/2003US20030032060 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/13/2003US20030032057 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/13/2003US20030032023 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders
02/13/2003US20030032010 Methods of populating data structures for use in evolutionary simulations
02/13/2003US20030031670 Diagnosis and treatment of malignant neoplasms
02/13/2003US20030031660 Administering to the subject a therapeutically effective amount of heparanase for inducing bone formation
02/13/2003US20030031654 Prohormone convertase transformed cells and polypeptide synthesis
02/13/2003US20030031649 Gene therapy to promote angiogenesis
02/13/2003DE10125540C1 Preparing concentrates of viruses that express nitric oxide synthase (NOS), for use in gene therapy of e.g. vascular disease, comprises growing producer cells in the presence of an NOS inhibitor
02/13/2003CA2838062A1 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
02/13/2003CA2456229A1 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
02/13/2003CA2456199A1 Gene associated with bone disorders
02/13/2003CA2456050A1 Caax prenyl protease nucleic acids and polypeptides and methods of use thereof
02/13/2003CA2456003A1 Regulator of calcineurin
02/13/2003CA2455555A1 Animal model for fatty acid amide-related neurobehaviors
02/13/2003CA2455365A1 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
02/13/2003CA2455163A1 Method for producing arachidonic acid in transgenic organisms
02/13/2003CA2455147A1 Pregnancy-related enzyme activity
02/13/2003CA2455038A1 Antigens of and antibodies to translocated molecules of microorganisms and uses thereof
02/13/2003CA2454899A1 Engineering of living cells for the expression of holo-phycobiliprotein-based constructs
02/13/2003CA2454850A1 Nucleic acids and encoded polypeptides associated with bipolar disorder
02/13/2003CA2454696A1 Novel genetic products of ashbya gossypii, associated with the mechanisms of signal transduction and especially with the improvement of vitamin b2 production
02/13/2003CA2454454A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
02/13/2003CA2454372A1 Fatty acid desaturase gene obtained from pomegranate and method for the production of unsaturated fatty acids
02/13/2003CA2454238A1 Method of detecting protease activity in a cell
02/13/2003CA2453840A1 Isp-1 and ctb-1 genes and uses thereof
02/13/2003CA2451142A1 Carotenoid ketolase gene
02/12/2003EP1283267A1 Vector for analysing replication mechanism of rna virus and use thereof
02/12/2003EP1283266A1 Transformant and process for producing polyester by using the same
02/12/2003EP1283265A1 Process for producing protein with reduction of acidic sugar chain and glycoprotein produced thereby
02/12/2003EP1283259A1 Chondroitin polymerase and DNA encoding the same
02/12/2003EP1283258A1 Ornithine decarboxylase similar protein and nucleic acid molecules encoding it
02/12/2003EP1283256A1 Method of culturing microorganism
02/12/2003EP1283215A2 Secreted polypeptide and nucleic acids encoding it
02/12/2003EP1282727A1 Methods for identifying candidate polynucleotide molecules encoding a protease
02/12/2003EP1282722A1 Stabilized proteins
02/12/2003EP1282719A1 Process for the preparation of dihydroxy esters and derivatives thereof
02/12/2003EP1282716A1 Method for producing recombinant proteins by gram-negative bacteria
02/12/2003EP1282715A2 Method for microbial production of difructose anhydride iii, micro-organism used therefor and enzyme with inulase ii activity and dna sequences coding therefor
02/12/2003EP1282714A2 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof
02/12/2003EP1282713A2 Moss genes from physcomitrella patens encoding proteins involved in the synthesis of polyunsaturated fatty acids and lipids
02/12/2003EP1282709A1 Method of modifying the content of cottonseed oil
02/12/2003EP1282700A1 Neuronal serine-threonine protein kinase
02/12/2003EP1282693A1 Human coagulation factor vii variants
02/12/2003EP1282688A1 Ammonia-oxidizing bacteria
02/12/2003EP1282686A1 A recombinant yeast for lignocellulose raw materials
02/12/2003EP1282684A2 Chondroitin synthase gene and methods of making and using same
02/12/2003EP1282669A2 Anti-fouling composition